ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
|
|
UKTrader54
|
82 |
31K |
0 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
82
|
31K
|
0
|
|
ASX - By Stock
|
DXB |
Re:
Ann: Investor Presentation
|
|
UKTrader54
|
75 |
19K |
5 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
75
|
19K
|
5
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: BARD1 Demonstrates Feasibility of SubB2M-Based IHC Test
|
|
UKTrader54
|
82 |
31K |
2 |
25/05/21 |
25/05/21 |
ASX - By Stock
|
82
|
31K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
11 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
732
|
150K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
9 |
24/05/21 |
24/05/21 |
ASX - By Stock
|
732
|
150K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
8 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
732
|
150K
|
8
|
|
ASX - By Stock
|
AHI |
Re:
Ann: AHI Signs Binding Term Sheet with Jana Care Inc
|
|
UKTrader54
|
25 |
5.0K |
2 |
20/05/21 |
20/05/21 |
ASX - By Stock
|
25
|
5.0K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Brian Leedman Reappointed as Executive Director
|
|
UKTrader54
|
63 |
21K |
4 |
19/05/21 |
19/05/21 |
ASX - By Stock
|
63
|
21K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
UKTrader54
|
15K |
7.1M |
3 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
15K
|
7.1M
|
3
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
|
|
UKTrader54
|
51 |
11K |
1 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
51
|
11K
|
1
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
|
|
UKTrader54
|
51 |
11K |
2 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
51
|
11K
|
2
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
|
|
UKTrader54
|
51 |
11K |
5 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
51
|
11K
|
5
|
|
ASX - By Stock
|
IMC |
Re:
Ann: IMM124E May Offer New Modality for Inhibition of SARS-CoV-2
|
|
UKTrader54
|
51 |
11K |
4 |
18/05/21 |
18/05/21 |
ASX - By Stock
|
51
|
11K
|
4
|
|
ASX - By Stock
|
IIQ |
Re:
Chart Thread
|
|
UKTrader54
|
1.4K |
559K |
3 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
1.4K
|
559K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Appendix 2A
|
|
UKTrader54
|
5 |
2.3K |
2 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
5
|
2.3K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
9 |
13/05/21 |
13/05/21 |
ASX - By Stock
|
732
|
150K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
5 |
12/05/21 |
12/05/21 |
ASX - By Stock
|
732
|
150K
|
5
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Placement closes oversubscribed-Bonus Option Issue launched
|
|
UKTrader54
|
238 |
58K |
6 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
238
|
58K
|
6
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
11 |
11/05/21 |
11/05/21 |
ASX - By Stock
|
732
|
150K
|
11
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
2 |
08/05/21 |
08/05/21 |
ASX - By Stock
|
732
|
150K
|
2
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
UKTrader54
|
98 |
19K |
9 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
98
|
19K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
UKTrader54
|
98 |
19K |
13 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
98
|
19K
|
13
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
UKTrader54
|
98 |
19K |
8 |
30/04/21 |
30/04/21 |
ASX - By Stock
|
98
|
19K
|
8
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
|
|
UKTrader54
|
176 |
56K |
3 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
176
|
56K
|
3
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Race Initiates Heart Safety Preclinical Study for Bisantrene
|
|
UKTrader54
|
176 |
56K |
4 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
176
|
56K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Epichem OHD Presentation - Waste to Fuels Technology
|
|
UKTrader54
|
9 |
2.4K |
9 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
9
|
2.4K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
UKTrader54
|
98 |
19K |
7 |
28/04/21 |
28/04/21 |
ASX - By Stock
|
98
|
19K
|
7
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Change in substantial holding
|
|
UKTrader54
|
71 |
25K |
2 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
71
|
25K
|
2
|
|
ASX - By Stock
|
RAC |
Re:
Ann: Quarterly Activity Report & Appendix 4C
|
|
UKTrader54
|
52 |
17K |
0 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
52
|
17K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
8 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
732
|
150K
|
8
|
|
ASX - By Stock
|
PAA |
Re:
PharmAust General Update - Kicking goals
|
|
UKTrader54
|
29 |
5.5K |
24 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
29
|
5.5K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Phase IIb Canine Trial Identifies Therapeutic Window for MPL
|
|
UKTrader54
|
98 |
19K |
25 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
98
|
19K
|
25
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Ceasing to be a substantial holder
|
|
UKTrader54
|
16 |
7.3K |
5 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
16
|
7.3K
|
5
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
8 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
732
|
150K
|
8
|
|
ASX - By Stock
|
DXB |
Re:
Ann: COVID-19 Study Recruits Multiple Patients in Europe
|
|
UKTrader54
|
100 |
33K |
4 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
100
|
33K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
UKTrader54
|
189 |
42K |
5 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
189
|
42K
|
5
|
|
ASX - By Stock
|
CHM |
Re:
Ann: Successful Completion of First Patient Cohort Phase 1 Trial
|
|
UKTrader54
|
36 |
11K |
9 |
22/04/21 |
22/04/21 |
ASX - By Stock
|
36
|
11K
|
9
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
11 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
732
|
150K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Ceasing to be a substantial holder
|
|
UKTrader54
|
25 |
8.9K |
2 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
25
|
8.9K
|
2
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3G
|
|
UKTrader54
|
9 |
3.0K |
6 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
9
|
3.0K
|
6
|
|
ASX - By Stock
|
ADO |
Re:
SP . Price movement
|
|
UKTrader54
|
3.3K |
1.1M |
22 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
3.3K
|
1.1M
|
22
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
UKTrader54
|
189 |
42K |
13 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
189
|
42K
|
13
|
|
ASX - By Stock
|
ATH |
Re:
Ann: Appendix 3G
|
|
UKTrader54
|
9 |
3.0K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
9
|
3.0K
|
1
|
|
ASX - By Stock
|
CHM |
Re:
The Big Churn
|
|
UKTrader54
|
22 |
9.2K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
22
|
9.2K
|
1
|
|
ASX - By Stock
|
IIQ |
Re:
Ann: Commencement of Legal Proceedings Against BARD1
|
|
UKTrader54
|
133 |
54K |
0 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
133
|
54K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
PPL-1 and results with my dog
|
|
UKTrader54
|
189 |
42K |
10 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
189
|
42K
|
10
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
5 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
732
|
150K
|
5
|
|
ASX - By Stock
|
ATX |
Re:
Ann: ATX FAK Inhibitors Reduce Fibrosis in Animal Model of NASH
|
|
UKTrader54
|
16 |
4.6K |
1 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
16
|
4.6K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Leiden Testing Indicates MPL SARS-CoV-2 Antiviral Activity
|
|
UKTrader54
|
732 |
150K |
11 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
732
|
150K
|
11
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp appoints VP, Commercial to progress growth strategy
|
|
UKTrader54
|
231 |
80K |
5 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
231
|
80K
|
5
|
|